Filing Details

Accession Number:
0001578563-20-000011
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-04-03 17:40:11
Reporting Period:
2020-04-01
Accepted Time:
2020-04-03 17:40:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1330436 Liquidia Technologies Inc LQDA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1033409 N Fredric Eshelman C/O Eshelman Ventures, Llc
319 N. 3Rd Street, Suite 301
Wilmington NC 28401
No No Yes No
1706673 Eshelman Ventures, Llc 319 N. 3Rd Street, Suite 301
Wilmington NC 28401
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-04-01 45,000 $4.89 89,100 No 4 P Indirect By Fred Eshelman, manager of Eshelman Ventures, LLC
Common Stock Acquisiton 2020-04-02 7,223 $4.96 96,323 No 4 P Indirect By Fred Eshelman, manager of Eshelman Ventures, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Fred Eshelman, manager of Eshelman Ventures, LLC
No 4 P Indirect By Fred Eshelman, manager of Eshelman Ventures, LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,159,744 Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $4.64 to $4.98. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the trades were effected.
  2. This transaction was executed in multiple trades at prices ranging from $4.91 to $4.99. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the trades were effected.
  3. The securities reported as directly beneficially owned by the Reporting Person may be deemed to be indirectly beneficially owned by the Dr. Eshelman, who is the manager of the Reporting Person.